Evaluation of thyroid eye disease: quality-of-life questionnaire (TED-QOL) in Korean patients

Estcourt, 2011, Quality of life in thyroid eye disease: impact of quality of care, Eur J Endocrinol, 164, 649, 10.1530/EJE-11-0055 Terwee, 1998, Development of a disease specific quality of life questionnaire for patients with Graves’ ophthalmopathy: the GO-QOL, Br J Ophthalmol, 82, 773, 10.1136/bjo.82.7.773 Terwee, 1999, Test-retest reliability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves’ ophthalmopathy, J Clin Epidemiol, 52, 875, 10.1016/S0895-4356(99)00069-4 Ponto, 2011, Quality of life in a german graves orbitopathy population, Am J Ophthalmol, 152, 483, 10.1016/j.ajo.2011.02.018 Choi, 2012, Assessing Graves’ ophthalmopathy-specific quality of life in Korean patients, Eye (Lond), 26, 544, 10.1038/eye.2011.359 Park, 2004, Assessing quality of life in Australian patients with Graves’ ophthalmopathy, Br J Ophthalmol, 88, 75, 10.1136/bjo.88.1.75 Wiersinga, 2006, Clinical assessment of patients with Graves’ orbitopathy: the European Group on Graves’ Orbitopathy recommendations to generalists, specialists and clinical researchers, Eur J Endocrinol, 155, 387, 10.1530/eje.1.02230 Fayers, 2011, Validity and reliability of the TED-QOL: a new three-item questionnaire to assess quality of life in thyroid eye disease, Br J Ophthalmol, 95, 1670, 10.1136/bjophthalmol-2011-300487 Guillemin, 1993, Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines, J Clin Epidemiol, 46, 1417, 10.1016/0895-4356(93)90142-N Mourits, 1989, Clinical criteria for the assessment of disease activity in Graves’ ophthalmopathy: a novel approach, Br J Ophthalmol, 73, 639, 10.1136/bjo.73.8.639 Dolman, 2006, VISA Classification for Graves orbitopathy, Ophthal Plast Reconstr Surg, 22, 319, 10.1097/01.iop.0000235499.34867.85 Eckstein, 2006, Thyrotropin receptor autoantibodies are independent risk factors for Graves’ ophthalmopathy and help to predict severity and outcome of the disease, J Clin Endocrinol Metab, 91, 3464, 10.1210/jc.2005-2813 Bartalena, 2008, Consensus statement of the European group on Graves’ orbitopathy (EUGOGO) on management of Graves’ orbitopathy, Thyroid, 18, 333, 10.1089/thy.2007.0315 Gorman, 2002, Radiotherapy for Graves’ ophthalmopathy: results at one year, Thyroid, 12, 251, 10.1089/105072502753600232 de Boer, 2004, Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life?, Qual Life Res, 13, 311, 10.1023/B:QURE.0000018499.64574.1f Bradley, 2006, Evaluation of the National Eye Institute visual function questionnaire in Graves’ ophthalmopathy, Ophthalmology, 113, 1450, 10.1016/j.ophtha.2006.02.060 Diener, 2003, culture, and subjective well-being: emotional and cognitive evaluations of life, Annu Rev Psychol, 54, 403, 10.1146/annurev.psych.54.101601.145056 Lee, 2000, The pleasures and pains of distinct self-construals: the role of interdependence in regulatory focus, J Pers Soc Psychol, 78, 1122, 10.1037/0022-3514.78.6.1122 Nilchaikovit, 1993, The effects of culture on illness behavior and medical care. Asian and American differences, Gen Hosp Psychiatry, 15, 41, 10.1016/0163-8343(93)90090-B Coulter, 2007, Psychological implications of Graves’ orbitopathy, Eur J Endocrinol, 157, 127, 10.1530/EJE-07-0205 McHorney, 1995, Individual-patient monitoring in clinical practice: are available health status surveys adequate?, Qual Life Res, 4, 293, 10.1007/BF01593882